Novel combination of glucocorticoids and PDE-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and COPD
Details for Australian Patent Application No. 2003255365 (hide)
International Classifications
Event Publications
6 November 2003 Complete Application Filed
Priority application(s): 102 36 688.8 09.08.02 DE
6 May 2004 Application Open to Public Inspection
Published as AU-B-2003255365
24 April 2008 Alteration of Name
The name of the applicant has been altered to MEDA Pharma GmbH & Co. KG
19 February 2009 Application Accepted
Published as AU-B-2003255365
18 June 2009 Standard Patent Sealed
3 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003255366-CONPOSITIONS WHICH COMPRISE POLYORGANOSILOXANES WITH QUATERNARY AMMONIUM GROUPS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser